1 Respiratory Drug Market Overview 1.1 Product Overview and Scope of Respiratory Drug 1.2 Respiratory Drug Segment by Type 1.2.1 Global Respiratory Drug Sales Growth Rate Comparison by Type (2022-2028) 1.2.2 Inhalable & Nasal Spray 1.2.3 Oral 1.2.4 Others 1.3 Respiratory Drug Segment by Application 1.3.1 Global Respiratory Drug Sales Comparison by Application: (2022-2028) 1.3.2 Hospital 1.3.3 Drugs Store 1.4 Global Respiratory Drug Market Size Estimates and Forecasts 1.4.1 Global Respiratory Drug Revenue 2017-2028 1.4.2 Global Respiratory Drug Sales 2017-2028 1.4.3 Respiratory Drug Market Size by Region: 2017 Versus 2021 Versus 2028 2 Respiratory Drug Market Competition by Manufacturers 2.1 Global Respiratory Drug Sales Market Share by Manufacturers (2017-2022) 2.2 Global Respiratory Drug Revenue Market Share by Manufacturers (2017-2022) 2.3 Global Respiratory Drug Average Price by Manufacturers (2017-2022) 2.4 Manufacturers Respiratory Drug Manufacturing Sites, Area Served, Product Type 2.5 Respiratory Drug Market Competitive Situation and Trends 2.5.1 Respiratory Drug Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Respiratory Drug Players Market Share by Revenue 2.5.3 Global Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Respiratory Drug Retrospective Market Scenario by Region 3.1 Global Respiratory Drug Retrospective Market Scenario in Sales by Region: 2017-2022 3.2 Global Respiratory Drug Retrospective Market Scenario in Revenue by Region: 2017-2022 3.3 North America Respiratory Drug Market Facts & Figures by Country 3.3.1 North America Respiratory Drug Sales by Country 3.3.2 North America Respiratory Drug Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Respiratory Drug Market Facts & Figures by Country 3.4.1 Europe Respiratory Drug Sales by Country 3.4.2 Europe Respiratory Drug Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Respiratory Drug Market Facts & Figures by Region 3.5.1 Asia Pacific Respiratory Drug Sales by Region 3.5.2 Asia Pacific Respiratory Drug Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Respiratory Drug Market Facts & Figures by Country 3.6.1 Latin America Respiratory Drug Sales by Country 3.6.2 Latin America Respiratory Drug Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Respiratory Drug Market Facts & Figures by Country 3.7.1 Middle East and Africa Respiratory Drug Sales by Country 3.7.2 Middle East and Africa Respiratory Drug Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 UAE 4 Global Respiratory Drug Historic Market Analysis by Type 4.1 Global Respiratory Drug Sales Market Share by Type (2017-2022) 4.2 Global Respiratory Drug Revenue Market Share by Type (2017-2022) 4.3 Global Respiratory Drug Price by Type (2017-2022) 5 Global Respiratory Drug Historic Market Analysis by Application 5.1 Global Respiratory Drug Sales Market Share by Application (2017-2022) 5.2 Global Respiratory Drug Revenue Market Share by Application (2017-2022) 5.3 Global Respiratory Drug Price by Application (2017-2022) 6 Key Companies Profiled 6.1 GSK 6.1.1 GSK Corporation Information 6.1.2 GSK Description and Business Overview 6.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.1.4 GSK Respiratory Drug Product Portfolio 6.1.5 GSK Recent Developments/Updates 6.2 AstraZeneca 6.2.1 AstraZeneca Corporation Information 6.2.2 AstraZeneca Description and Business Overview 6.2.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.2.4 AstraZeneca Respiratory Drug Product Portfolio 6.2.5 AstraZeneca Recent Developments/Updates 6.3 Boehringer Ingelheim 6.3.1 Boehringer Ingelheim Corporation Information 6.3.2 Boehringer Ingelheim Description and Business Overview 6.3.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.3.4 Boehringer Ingelheim Respiratory Drug Product Portfolio 6.3.5 Boehringer Ingelheim Recent Developments/Updates 6.4 Vertex 6.4.1 Vertex Corporation Information 6.4.2 Vertex Description and Business Overview 6.4.3 Vertex Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Vertex Respiratory Drug Product Portfolio 6.4.5 Vertex Recent Developments/Updates 6.5 Roche 6.5.1 Roche Corporation Information 6.5.2 Roche Description and Business Overview 6.5.3 Roche Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.5.4 Roche Respiratory Drug Product Portfolio 6.5.5 Roche Recent Developments/Updates 6.6 Novartis 6.6.1 Novartis Corporation Information 6.6.2 Novartis Description and Business Overview 6.6.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.6.4 Novartis Respiratory Drug Product Portfolio 6.6.5 Novartis Recent Developments/Updates 6.7 Teva 6.6.1 Teva Corporation Information 6.6.2 Teva Description and Business Overview 6.6.3 Teva Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.4.4 Teva Respiratory Drug Product Portfolio 6.7.5 Teva Recent Developments/Updates 6.8 Chiesi 6.8.1 Chiesi Corporation Information 6.8.2 Chiesi Description and Business Overview 6.8.3 Chiesi Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.8.4 Chiesi Respiratory Drug Product Portfolio 6.8.5 Chiesi Recent Developments/Updates 6.9 Mylan 6.9.1 Mylan Corporation Information 6.9.2 Mylan Description and Business Overview 6.9.3 Mylan Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.9.4 Mylan Respiratory Drug Product Portfolio 6.9.5 Mylan Recent Developments/Updates 6.10 Sumitomo Dainippon 6.10.1 Sumitomo Dainippon Corporation Information 6.10.2 Sumitomo Dainippon Description and Business Overview 6.10.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.10.4 Sumitomo Dainippon Respiratory Drug Product Portfolio 6.10.5 Sumitomo Dainippon Recent Developments/Updates 6.11 Merck 6.11.1 Merck Corporation Information 6.11.2 Merck Respiratory Drug Description and Business Overview 6.11.3 Merck Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.11.4 Merck Respiratory Drug Product Portfolio 6.11.5 Merck Recent Developments/Updates 6.12 Beximco 6.12.1 Beximco Corporation Information 6.12.2 Beximco Respiratory Drug Description and Business Overview 6.12.3 Beximco Respiratory Drug Sales, Revenue and Gross Margin (2017-2022) 6.12.4 Beximco Respiratory Drug Product Portfolio 6.12.5 Beximco Recent Developments/Updates 7 Respiratory Drug Manufacturing Cost Analysis 7.1 Respiratory Drug Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Respiratory Drug 7.4 Respiratory Drug Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Respiratory Drug Distributors List 8.3 Respiratory Drug Customers 9 Respiratory Drug Market Dynamics 9.1 Respiratory Drug Industry Trends 9.2 Respiratory Drug Market Drivers 9.3 Respiratory Drug Market Challenges 9.4 Respiratory Drug Market Restraints 10 Global Market Forecast 10.1 Respiratory Drug Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Respiratory Drug by Type (2023-2028) 10.1.2 Global Forecasted Revenue of Respiratory Drug by Type (2023-2028) 10.2 Respiratory Drug Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Respiratory Drug by Application (2023-2028) 10.2.2 Global Forecasted Revenue of Respiratory Drug by Application (2023-2028) 10.3 Respiratory Drug Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Respiratory Drug by Region (2023-2028) 10.3.2 Global Forecasted Revenue of Respiratory Drug by Region (2023-2028) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Respiratory Drug Sales Growth Rate Comparison by Type (2022-2028) & (M Units) & (US$ Million) Table 2. Global Respiratory Drug Sales Growth Rate Comparison by Application (2022-2028) & (M Units) & (US$ Million) Table 3. Global Respiratory Drug Market Size by Region (US$ Million) (2017 VS 2021 VS 2028) Table 4. Global Respiratory Drug Market Competitive Situation by Manufacturers in 2021 Table 5. Global Respiratory Drug Sales (M Units) of Key Manufacturers (2017-2022) Table 6. Global Respiratory Drug Sales Market Share by Manufacturers (2017-2022) Table 7. Global Respiratory Drug Revenue (US$ Million) by Manufacturers (2017-2022) Table 8. Global Respiratory Drug Revenue Share by Manufacturers (2017-2022) Table 9. Global Market Respiratory Drug Average Price (US$/Unit) of Key Manufacturers (2017-2022) Table 10. Manufacturers Respiratory Drug Manufacturing Sites and Area Served Table 11. Manufacturers Respiratory Drug Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Respiratory Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Drug as of 2021) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Respiratory Drug Sales by Region (2017-2022) & (M Units) Table 16. Global Respiratory Drug Sales Market Share by Region (2017-2022) Table 17. Global Respiratory Drug Revenue by Region (2017-2022) & (US$ Million) Table 18. Global Respiratory Drug Revenue Market Share by Region (2017-2022) Table 19. North America Respiratory Drug Sales by Country (2017-2022) & (M Units) Table 20. North America Respiratory Drug Sales Market Share by Country (2017-2022) Table 21. North America Respiratory Drug Revenue by Country (2017-2022) & (US$ Million) Table 22. North America Respiratory Drug Revenue Market Share by Country (2017-2022) Table 23. Europe Respiratory Drug Sales by Country (2017-2022) & (M Units) Table 24. Europe Respiratory Drug Sales Market Share by Country (2017-2022) Table 25. Europe Respiratory Drug Revenue by Country (2017-2022) & (US$ Million) Table 26. Europe Respiratory Drug Revenue Market Share by Country (2017-2022) Table 27. Asia Pacific Respiratory Drug Sales by Region (2017-2022) & (M Units) Table 28. Asia Pacific Respiratory Drug Sales Market Share by Region (2017-2022) Table 29. Asia Pacific Respiratory Drug Revenue by Region (2017-2022) & (US$ Million) Table 30. Asia Pacific Respiratory Drug Revenue Market Share by Region (2017-2022) Table 31. Latin America Respiratory Drug Sales by Country (2017-2022) & (M Units) Table 32. Latin America Respiratory Drug Sales Market Share by Country (2017-2022) Table 33. Latin America Respiratory Drug Revenue by Country (2017-2022) & (US$ Million) Table 34. Latin America Respiratory Drug Revenue Market Share by Country (2017-2022) Table 35. Middle East and Africa Respiratory Drug Sales by Country (2017-2022) & (M Units) Table 36. Middle East and Africa Respiratory Drug Sales Market Share by Country (2017-2022) Table 37. Middle East and Africa Respiratory Drug Revenue by Country (2017-2022) & (US$ Million) Table 38. Middle East and Africa Respiratory Drug Revenue Market Share by Country (2017-2022) Table 39. Global Respiratory Drug Sales by Type (2017-2022) & (M Units) Table 40. Global Respiratory Drug Sales Market Share by Type (2017-2022) Table 41. Global Respiratory Drug Revenue by Type (2017-2022) & (US$ Million) Table 42. Global Respiratory Drug Revenue Share by Type (2017-2022) Table 43. Global Respiratory Drug Price by Type (2017-2022) & (US$/Unit) Table 44. Global Respiratory Drug Sales (M Units) by Application (2017-2022) Table 45. Global Respiratory Drug Sales Market Share by Application (2017-2022) Table 46. Global Respiratory Drug Revenue by Application (2017-2022) & (US$ Million) Table 47. Global Respiratory Drug Revenue Share by Application (2017-2022) Table 48. Global Respiratory Drug Price by Application (2017-2022) & (US$/Unit) Table 49. GSK Corporation Information Table 50. GSK Description and Business Overview Table 51. GSK Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 52. GSK Respiratory Drug Product Table 53. GSK Recent Developments/Updates Table 54. AstraZeneca Corporation Information Table 55. AstraZeneca Description and Business Overview Table 56. AstraZeneca Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 57. AstraZeneca Respiratory Drug Product Table 58. AstraZeneca Recent Developments/Updates Table 59. Boehringer Ingelheim Corporation Information Table 60. Boehringer Ingelheim Description and Business Overview Table 61. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 62. Boehringer Ingelheim Respiratory Drug Product Table 63. Boehringer Ingelheim Recent Developments/Updates Table 64. Vertex Corporation Information Table 65. Vertex Description and Business Overview Table 66. Vertex Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 67. Vertex Respiratory Drug Product Table 68. Vertex Recent Developments/Updates Table 69. Roche Corporation Information Table 70. Roche Description and Business Overview Table 71. Roche Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 72. Roche Respiratory Drug Product Table 73. Roche Recent Developments/Updates Table 74. Novartis Corporation Information Table 75. Novartis Description and Business Overview Table 76. Novartis Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 77. Novartis Respiratory Drug Product Table 78. Novartis Recent Developments/Updates Table 79. Teva Corporation Information Table 80. Teva Description and Business Overview Table 81. Teva Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 82. Teva Respiratory Drug Product Table 83. Teva Recent Developments/Updates Table 84. Chiesi Corporation Information Table 85. Chiesi Description and Business Overview Table 86. Chiesi Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 87. Chiesi Respiratory Drug Product Table 88. Chiesi Recent Developments/Updates Table 89. Mylan Corporation Information Table 90. Mylan Description and Business Overview Table 91. Mylan Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 92. Mylan Respiratory Drug Product Table 93. Mylan Recent Developments/Updates Table 94. Sumitomo Dainippon Corporation Information Table 95. Sumitomo Dainippon Description and Business Overview Table 96. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 97. Sumitomo Dainippon Respiratory Drug Product Table 98. Sumitomo Dainippon Recent Developments/Updates Table 99. Merck Corporation Information Table 100. Merck Description and Business Overview Table 101. Merck Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 102. Merck Respiratory Drug Product Table 103. Merck Recent Developments/Updates Table 104. Beximco Corporation Information Table 105. Beximco Description and Business Overview Table 106. Beximco Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022) Table 107. Beximco Respiratory Drug Product Table 108. Beximco Recent Developments/Updates Table 109. Production Base and Market Concentration Rate of Raw Material Table 110. Key Suppliers of Raw Materials Table 111. Respiratory Drug Distributors List Table 112. Respiratory Drug Customers List Table 113. Respiratory Drug Market Trends Table 114. Respiratory Drug Market Drivers Table 115. Respiratory Drug Market Challenges Table 116. Respiratory Drug Market Restraints Table 117. Global Respiratory Drug Sales Forecast by Type (2023-2028) & (M Units) Table 118. Global Respiratory Drug Sales Market Share Forecast by Type (2023-2028) Table 119. Global Respiratory Drug Revenue Forecast by Type (2023-2028) & (US$ Million) Table 120. Global Respiratory Drug Revenue Market Share Forecast by Type (2023-2028) Table 121. Global Respiratory Drug Sales Forecast by Application (2023-2028) & (M Units) Table 122. Global Respiratory Drug Sales Market Share Forecast by Application (2023-2028) Table 123. Global Respiratory Drug Revenue Forecast by Application (2023-2028) & (US$ Million) Table 124. Global Respiratory Drug Revenue Market Share Forecast by Application (2023-2028) Table 125. Global Respiratory Drug Sales Forecast by Region (2023-2028) & (M Units) Table 126. Global Respiratory Drug Sales Market Share Forecast by Region (2023-2028) Table 127. Global Respiratory Drug Revenue Forecast by Region (2023-2028) & (US$ Million) Table 128. Global Respiratory Drug Revenue Market Share Forecast by Region (2023-2028) Table 129. Research Programs/Design for This Report Table 130. Key Data Information from Secondary Sources Table 131. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Respiratory Drug Figure 2. Global Respiratory Drug Market Share by Type in 2021 & 2028 Figure 3. Inhalable & Nasal Spray Product Picture Figure 4. Oral Product Picture Figure 5. Others Product Picture Figure 6. Global Respiratory Drug Market Share by Application in 2021 & 2028 Figure 7. Hospital Figure 8. Drugs Store Figure 9. Global Respiratory Drug Revenue, (US$ Million), 2017 VS 2021 VS 2028 Figure 10. Global Respiratory Drug Market Size (2017-2028) & (US$ Million) Figure 11. Global Respiratory Drug Sales (2017-2028) & (M Units) Figure 12. Respiratory Drug Sales Share by Manufacturers in 2021 Figure 13. Global Respiratory Drug Revenue Share by Manufacturers in 2021 Figure 14. The Global 5 and 10 Largest Respiratory Drug Players: Market Share by Revenue in 2021 Figure 15. Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021 Figure 16. Global Respiratory Drug Sales Market Share by Region (2017-2022) Figure 17. Global Respiratory Drug Sales Market Share by Region in 2021 Figure 18. Global Respiratory Drug Revenue Market Share by Region (2017-2022) Figure 19. Global Respiratory Drug Revenue Market Share by Region in 2021 Figure 20. U.S. Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 21. Canada Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 22. Germany Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 23. France Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 24. U.K. Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 25. Italy Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 26. Russia Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 27. China Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 28. Japan Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 29. South Korea Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 30. India Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 31. Australia Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 32. Taiwan Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 33. Indonesia Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 34. Thailand Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 35. Malaysia Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 36. Philippines Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 37. Vietnam Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 38. Mexico Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 39. Brazil Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 40. Argentina Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 41. Turkey Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 42. Saudi Arabia Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 43. UAE Respiratory Drug Revenue Growth Rate (2017-2022) & (US$ Million) Figure 44. Sales Market Share of Respiratory Drug by Type (2017-2022) Figure 45. Manufacturing Cost Structure of Respiratory Drug Figure 46. Manufacturing Process Analysis of Respiratory Drug Figure 47. Respiratory Drug Industrial Chain Analysis Figure 48. Channels of Distribution Figure 49. Distributors Profiles Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

GSK AstraZeneca Boehringer Ingelheim Vertex Roche Novartis Teva Chiesi Mylan Sumitomo Dainippon Merck Beximco